BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17109648)

  • 1. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
    Fowler CJ
    Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anandamide: an update.
    Smita K; Sushil Kumar V; Premendran JS
    Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
    Snider NT; Walker VJ; Hollenberg PF
    Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and synthetic endocannabinoids and their structure-activity relationships.
    Palmer SL; Khanolkar AD; Makriyannis A
    Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
    J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
    Schlosburg JE; Kinsey SG; Lichtman AH
    AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous cannabinoids: structure and metabolism.
    Bisogno T
    J Neuroendocrinol; 2008 May; 20 Suppl 1():1-9. PubMed ID: 18426492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
    Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V
    Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
    McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
    Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
    Cravatt BF; Lichtman AH
    Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
    Gertsch J
    Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide uptake explained?
    Fowler CJ
    Trends Pharmacol Sci; 2012 Apr; 33(4):181-5. PubMed ID: 22297258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
    De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
    Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of anxiety through blockade of anandamide hydrolysis.
    Kathuria S; Gaetani S; Fegley D; Valiño F; Duranti A; Tontini A; Mor M; Tarzia G; La Rana G; Calignano A; Giustino A; Tattoli M; Palmery M; Cuomo V; Piomelli D
    Nat Med; 2003 Jan; 9(1):76-81. PubMed ID: 12461523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.